From: Efgartigimod Alfa (Vyvgart)
Efgartigimod Alfa (Vyvgart): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with generalized myasthenia gravis who are anti-acetylcholine receptor antibody positive [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Jan.
Copyright Notice
Copyright © 2024 - Canadian Agency for Drugs and Technologies in Health. Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial- NoDerivatives 4.0 International licence (CC BY-NC-ND).
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.